Nasdaq

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.
Seeking Alpha

Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities

The new cobas ® 6800/8800 Systems version 2.0 and software version 2.0.1 enhances throughput, run flexibility, enables sample prioritization and is available as an upgrade to existing systems.
Nasdaq

Roche Gets CE Mark For New Molecular Cobas 6800/8800 Systems - Quick Facts

(RTTNews) - Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The company said the new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables ...
CNN

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer

More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...
Reuters

Roche receives FDA approval for CMV viral load testing on cobas 6800/8800 systems

* Roche Holding Ag says in addition to CMV assay, Roche has FDA-approved viral load tests for hiv-1, hcv and hbv for cobas 6800/8800 system Source text for Eikon: Further company coverage: ...
Morningstar

Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities

INDIANAPOLIS, Dec. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software version 2.0.1, following U.S.